臨床症狀不明顯的甲狀腺功能低下(TSH>2.5 mIU/L, T3, T4 正常)占習慣性流產病患之19%
http://humrep.oxfordjournals.org/content/early/2013/06/10/humrep.det251.abstract
Fertil Steril. 2013 Aug 15. pii: S0015-0282(13)02761-1. doi: 10.1016/j.fertnstert.2013.07.1975. [Epub ahead of print]
Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss.
Source
University of Chicago Recurrent Pregnancy Loss Program, Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois; Department of Obstetrics and Gynecology, University of Illinois, Chicago, Illinois.
Abstract
OBJECTIVE:
To assess the impact of subclinical hypothyroidism (SCH) in women with recurrent early pregnancy loss (REPL).
DESIGN:
Observational cohort study.
SETTING:
REPL program in an academic medical center.
PATIENT(S):
286 women with a history of ≥2 pregnancy losses <10 weeks.
INTERVENTION(S):
From 2004-2007, no treatment for women with SCH (thyroid-stimulating hormone [TSH] >2.5 mIU/L with a normal free thyroxine or free thyroxine index); from 2008 onward, levothyroxine treatment prepregnancy to maintain TSH ≤2.5 mIU/L.
MAIN OUTCOME MEASURE(S):
Live-birth rate (LBR).
RESULT(S):
The prevalence of SCH was 55 (19%) of 286 in this REPL cohort. The cumulative LBR was 27 (69%) of 39 for women with SCH versus 104 (74%) of 141 for euthyroid women. The per-pregnancy LBR was 34 (49%) of 69 for SCH versus 129 (58%) of 221 for euthyroid women. When the LBR was compared between treated and untreated SCH, the cumulative LBR was 17 (71%) of 24 versus 10 (67%) of 15, respectively. The per-pregnancy LBR for SCH treated versus untreated women was 22 (48%) of 46 versus 12 (52%) of 23, respectively.
CONCLUSION(S):
Although there was a high prevalence of SCH in the REPL cohort, there was no statistically significant difference in the subsequent live-birth rate when comparing women with SCH and euthyroid women, or treated and untreated SCH.
沒有留言:
張貼留言